This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2026 Remove Documentation Remove Dosage Related Topics
Packaging Chemotherapy Compounding Labelling Communication More Related Topics >
article thumbnail

Apixaban vs warfarin: rise of newer anticoagulant

Druggist

APRIL 29, 2021

Eliquis is still protected by patent rights in the UK, with exclusive availability rights until 2026 (IPO, 2021). . Additionally, the dosage is much simpler as compared to warfarin as it does not change generally after treatment initiation is completed. . In the UK, apixaban is known as a branded drug called Eliquis®.

Dosage 98
Dosage Chemotherapy Documentation Compounding 98
article thumbnail

Can holograms help in the frontline fight against pharmaceutical counterfeiting?

European Pharmaceutical Review

NOVEMBER 24, 2022

With predictions that the global market for anticounterfeiting packaging is set to reach almost $250 billion by 2026, growth in authentication and anti-tamper devices such as holograms appear to have a healthy future.” Blister packs can also benefit from anticounterfeiting holography.

Packaging 97
Packaging Labelling Documentation Dosage 97
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 18,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024